Antiarrhythmics Flashcards
PSVT
paroxysmal supraventricular tachycardia
predominant pacemaker
SA node
lethal arrhythmia
v. fib
causes of arrhythmia
digoxin (25%)
anesthesia (50%)
AMI (80%)
Slow response fibers
SA node
AV node
fast response fibers
Atria
Ventricles
Bundle of His
Purkinje cells
Highest automaticity
SA node (sets HR)
lethal arrhythmias can be causes by
antiarrhythmic agents
Channels for slow acting fiber (SA and AV)
calcium channels
ERP
shortest interval at which a premature stimulus results in a propagated response (phase 0., 1, 2, and most of 3)
ERP length of ADP
ERP is ~85% of APD
AP in purkinje cell phases
Phase 0: opening of Na channels, rapid depol, inactivaiton of Na channels
Phase 1: rapid partial repol due to inactivation of fast Na channels and increased K+c channel permeability
Phase 2: plateau: Ca (L-type) and some Na (“window” or late current” channels are open)
Phase 3: Repolarization: Ca channels inactivated and K+ channels open, Na channels turning to rest
Phase 4: resting membrane potential
SA node AP phases
Phase 4: funny sodium current (spontaneous depol)
Phase 0: T-type Ca open and start to depol, then L-type Ca cause AP
Phase 1: Ca channels close, K+ activated
Phase4: spontaneous regeneration via Na funny channels
Causes of arrhythmia
distrbuance in impulse generation
impulse conduction
both
Precipitating factors of arrhythmias
ischemia, hypoxemia alkalosis, electrolyte abrnomalities Excess catecholamines Drug toxicity (digoxin, antiarrhythmic) Overstretched fiber scarred/diseased tissue
Factors that decreases rate of pacemaker cells
Increase depol potential (more neg)
Increase AP duration
Increase slope of phase 4 depol (K+)
Increase threshold hypotential
Simple blocks
AV block
Bundle branch Block
Reentry mechanism
obstacle to homogenous conduction; unidirectional block; conduction time long enough to find excitable tissues
Aims of antiarrythmic therapy
reduce ectopic pacemaker activity
modify conduction or refractoriness to disable reentry
Mechanism of antiarrhythmic (sodium channel blockade)
Sodium channel block
block sympathetic effects (BB)
prolong ERP
Calcium channel blockade
Lengthen ERP
Active Na channel blockers (class 1a: quinidine, procainamide)
K+ channel blockers amiodarone, sotalol)
K+ channel blockers
amiodarone
sotalol
1a drugs
block activated Na channels; lenghten AP, inc. ERP
Quinidine, Procainamide
1b drugs
block inactivated Na channels
dec AP, dec ERP
Lidocaine
1c drugs
block all Na channels
no effect on AP, or ERP
Flecainide
Quinidine MOA
slows rate of rise (Vmax) in normal cells by blocking active Na+ channels
No depolarization in damaged cells
2ndary: Inhibits K+ channels (prolong AP and ERP)
When is quinidine used
“BROAD SPECTRUM”
acute and chronic supra and ventricular arrhythmias
rarely used due to effects